Psychological aspects of pre-symptomatic testing for Machado-Joseph disease and familial amyloid polyneuropathy type I

Clinical Genetics
L RolimM Fleming

Abstract

Machado-Joseph disease [MJD, also spinocerebellar ataxia type 3 (SCA3)] and familial amyloid polyneuropathy type I (FAP-I or ATTR V30M) are neurodegenerative disorders, inherited in an autosomal dominant fashion, which have a high prevalence in Portugal, probably due to a founder effect. MJD and FAP-I are late-onset diseases, with symptoms emerging usually during adulthood. CGPP, which is the national reference centre for these disorders, has a genetic lab that offers diagnostic, pre-symptomatic and prenatal testing and an outpatient clinic to counsel and follow relatives at risk for hereditary ataxias, FAP-I and Huntington disease (HD). The present work is a review of our 10-year experience with psychological counselling of individuals at risk for MJD and FAP-I. Persons at risk for FAP-I may show a better response to pre-symptomatic testing than those who are at risk for MJD and HD because of the availability of liver transplantation, which may improve their health and life expectancy. Psychological well-being and specific distress of MJD and FAP-I test applicants, before undergoing genetic testing (baseline level) and 3 to 6 months after disclosure of test results, have shown a low level of change, both in identified carriers...Continue Reading

References

Sep 1, 1992·American Journal of Medical Genetics·A TibbenD Stronks
Feb 1, 1987·American Journal of Medical Genetics·S KesslerH Mosbarger
Dec 1, 1974·Journal of Consulting and Clinical Psychology·A T BeckL Trexler
Nov 17, 1983·Nature·J F GusellaA Y Sakaguchi
Jan 1, 1994·Alzheimer Disease and Associated Disorders·A LennoxJ M Berg
Mar 1, 1996·Journal of the Neurological Sciences·T SakaiH Iwashita
Oct 10, 1997·Journal of Medical Genetics·D G EvansD Craufurd
Apr 2, 1998·BMJ : British Medical Journal·T M Marteau, R T Croyle
Jul 17, 1998·Prenatal Diagnosis·J SequeirosC S Jorge
Dec 22, 1999·American Journal of Medical Genetics·S K Sobel, D B Cowan
Jan 3, 2001·American Journal of Human Genetics·C GasparG A Rouleau
Nov 16, 2001·Archives of Neurology·P MacielJ Sequeiros
Apr 26, 2002·European Journal of Human Genetics : EJHG·Gerry Evers-KieboomsSheila Simpson
Jun 7, 2002·The New England Journal of Medicine·Maria João Mascarenhas Saraiva
Aug 27, 2002·Seminars in Neurology·T D Bird
Nov 5, 2002·Journal of Medical Genetics·M-N W Witjes-AnéR A C Roos
Mar 5, 2003·Acta Neurologica Scandinavica·T L MonteL B Jardim
Sep 17, 2003·Clinical Genetics·E W AlmqvistUNKNOWN Canadian Collaborative Study of Predictive Testing
Jun 1, 1961·Archives of General Psychiatry·A T BECKJ ERBAUGH
Feb 28, 2004·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·Takeshi HattoriShu-ichi Ikeda
Jun 5, 2004·Community Genetics·V B Penchaszadeh, D Puñales-Morejón
Jun 10, 2004·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·Luísa LobatoJorge Sequeiros

❮ Previous
Next ❯

Citations

Feb 24, 2007·Journal of Genetic Counseling·Milena PanequeJorge Sequeiros
Jan 26, 2011·Journal of Genetic Counseling·Tania Cruz MariñoLuis Velázquez Pérez
May 16, 2013·Journal of Community Genetics·Tania Cruz-MariñoMilena Paneque
Oct 9, 2001·Acta Neurologica Scandinavica·L B JardimR Giugliani
Jun 4, 2011·Orphanet Journal of Rare Diseases·Conceição Bettencourt, Manuela Lima
Dec 3, 2011·Progress in Neurobiology·Maria do Carmo Costa, Henry L Paulson
Apr 22, 2015·Journal of Community Genetics·Tania Cruz-MariñoMilena Paneque
Feb 13, 2016·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Susana LêdoJorge Sequeiros
Apr 26, 2014·Genetics and Molecular Biology·Lavínia Schuler-FacciniLaura Bannach Jardim
Jan 24, 2018·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·Alice LopesPaula Freitas
Mar 26, 2013·Rinshō shinkeigaku = Clinical neurology·Keiko TanakaYoshimitsu Fukushima
Jan 7, 2016·Current Opinion in Neurology·Laura ObiciUNKNOWN from the European Network for TTR-FAP (ATTReuNET)
Dec 24, 2018·European Journal of Human Genetics : EJHG·Álvaro MendesJorge Sequeiros
Jun 15, 2017·Cadernos de saúde pública·Carla Roma OliveiraLiliana Sousa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amyloidogenesis-associated Polyneuropathy

Amyloid deposits around nerves can damage and disrupt smooth information processing between the brain and organs. Here is the latest research on amyloidosis-associated polyneuropathies.

Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on different types of ataxias here.